Draft:Theodore C Friedman

  • Comment: This is a resume for a man who does not seem to be automatically eligible via WP:NPROF. The writing smacks of AI, but there's also no secondary sourcing that proves him notable. His own articles being used as references and a media coverage claim ("He has also been quoted in...") suggest that this is basically a LinkedIn entry. Drmies (talk) 15:37, 28 October 2025 (UTC)



Theodore C. Friedman
Born
CitizenshipAmerican
Alma materStanford University, Icahn School of Medicine at Mount Sinai, City University of New York
Scientific career
FieldsEndocrinology
InstitutionsCharles R. Drew University of Medicine and Science, UCLA, Cedars-Sinai Medical Center
Websitewww.goodhormonehealth.com

Theodore C. Friedman is an American endocrinologist and academic physician. He serves as the Chairman of the Department of Internal Medicine at Charles R. Drew University of Medicine and Science (CDU) and is a Professor of Medicine at the David Geffen School of Medicine at UCLA.[1] His research focuses on prohormone processing, the metabolic effects of electronic cigarettes, and diagnostic approaches to Cushing's syndrome.

Early life and education

edit

Friedman earned a B.S. in Chemistry and Biological Sciences from Stanford University in 1980. He completed a Ph.D. in Pharmacology at the City University of New York in 1986, studying thyrotropin-releasing hormone (TRH) degradation pathways.[2] He received his M.D. from the Icahn School of Medicine at Mount Sinai in 1987.

He completed an internal medicine residency at the University of Michigan followed by an endocrinology fellowship at the National Institutes of Health (NIH) from 1989 to 1995, where he worked on the Cushing’s ward.[3]

Academic career

edit

Friedman is the Chairman of Internal Medicine at CDU, where he holds an endowed professorship in Cardiometabolic Diseases. During his tenure, he oversaw the department during the establishment of CDU's independent four-year medical degree program, which received preliminary accreditation in 2022.[4]

He also serves as the Lead Physician of Endocrinology at the Martin Luther King Jr. Outpatient Center for the Los Angeles County Department of Health Services.[5]

Research

edit

Cushing's syndrome

edit

Friedman’s clinical research examines episodic (cyclical) hypercortisolism. He has argued that single diagnostic tests for Cushing's syndrome often yield false negatives, advocating for multiple testing modalities to identify fluctuating hormone production.[6]

Metabolic effects of e-cigarettes

edit

Funded by the National Institute on Drug Abuse (NIDA) and the Department of Defense, Friedman has researched the cardiovascular and hepatic impacts of nicotine. His work suggests that electronic cigarette exposure may contribute to liver fat accumulation and cardiac dysfunction.[7]

Thyroid and lifestyle medicine

edit

Friedman has investigated the role of Reverse T3 in hypothyroidism and developed protocols for treating Graves' disease in primary care settings.[8]

References

edit
  1. "Theodore Friedman Faculty Profile". Charles R. Drew University. Retrieved March 19, 2026.
  2. Friedman, TC (1986). "Delineation of a particulate thyrotropin-releasing hormone degrading enzyme in rat brain". Journal of Neurochemistry. 46 (4): 1231–1239.
  3. "Theodore Friedman Profile". UCLA. Retrieved March 19, 2026.
  4. Newberry, Laura (October 11, 2022). "Charles R. Drew University medical school gets preliminary accreditation". Los Angeles Times.
  5. "DHS Diabetes/Endocrinology Work Group". Los Angeles County Department of Health Services. Retrieved March 19, 2026.
  6. "Doctor Advances Understanding of Cyclical Cushing's". Endocrine News. Retrieved March 19, 2026.
  7. Endocrine Society (March 18, 2018). "E-cigarettes may lead to accumulation of fat in the liver". Endocrine.org.
  8. Bever, Lindsey (April 4, 2017). "Is adrenal fatigue real? Forget the label and treat the stress". The Washington Post.